Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083

Stephen R. Walsh(Beth Israel Deaconess Medical Center), Xia Jin(Anhui Medical University), Zoe Moodie(Fred Hutch Cancer Center), Barney S. Graham(National Institutes of Health), Susan Buchbinder(University of California, San Francisco), Paul Goepfert(University of Maryland, Baltimore), Cecilia Morgan(Fred Hutch Cancer Center), Georgia D. Tomaras(National Institutes of Health), Andrew Fioré-Gartland(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Edith Swann(National Institutes of Health), Nicole Frahm(Fred Hutch Cancer Center), Hasan Ahmed(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Mark J. Mulligan(New York University), Spyros A. Kalams(Vanderbilt University Medical Center), Shannon Grant(Fred Hutch Cancer Center), M. Juliana McElrath(Fred Hutch Cancer Center), Lindsey R. Baden(Brigham and Women's Hospital), David Friedrich(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Marissa B. Wilck(Brigham and Women's Hospital), Fusheng Li(Guangxi University), John Hural(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Steven G. Self(Fred Hutch Cancer Center), Scott M. Hammer, Michael C. Keefer(University of Rochester Medical Center), David C. Montefiori(Duke University), Hua-Xin Liao(Duke University), Tomer Hertz(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa)
The Journal of Infectious Diseases
October 15, 2015
Cited by 25


Related Papers